| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Heissig B | |
| Hattori K | |||
| Rafii S | |||
| P2860 | cites work | Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 |
| Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning | Q24310148 | ||
| Angiopoietin-1 induces sprouting angiogenesis in vitro | Q24310303 | ||
| Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform | Q24311517 | ||
| Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 | Q24314336 | ||
| Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains | Q24561693 | ||
| Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 | ||
| Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice | Q24681021 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell | Q28188430 | ||
| Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth | Q28203327 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells | Q28285435 | ||
| Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis | Q28300359 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract | Q28504884 | ||
| Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors | Q28504989 | ||
| Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development | Q28512895 | ||
| Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 | Q28513759 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| Chemokines--chemotactic cytokines that mediate inflammation | Q29616433 | ||
| Lymphocyte homing and homeostasis | Q29619924 | ||
| Hematopoietic deficiencies in c-mpl and TPO knockout mice | Q33501697 | ||
| Regulation of transendothelial migration of hematopoietic progenitor cells | Q33661855 | ||
| The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen | Q33859887 | ||
| The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment | Q77402792 | ||
| Marrow engraftment of hematopoietic stem and progenitor cells is independent of Galphai-coupled chemokine receptors | Q77787558 | ||
| Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 | Q77952550 | ||
| Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture | Q78124870 | ||
| Modulation of haematopoietic progenitor development by FLT-3 ligand | Q78232910 | ||
| Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization | Q33870103 | ||
| KDR receptor: a key marker defining hematopoietic stem cells | Q33873300 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| The evolving concept of a stem cell: entity or function? | Q34299883 | ||
| Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. | Q34847758 | ||
| In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells | Q35066876 | ||
| Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. | Q35597273 | ||
| Blood-borne seeding by hematopoietic and endothelial precursors from the allantois | Q35878264 | ||
| Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis | Q36237297 | ||
| A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution | Q36363874 | ||
| Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. | Q36369295 | ||
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. | Q36376700 | ||
| Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation | Q36401529 | ||
| Genomic organization of human and mouse genes for vascular endothelial growth factor C. | Q36884488 | ||
| Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. | Q37303158 | ||
| A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit | Q37604867 | ||
| A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection | Q39290210 | ||
| Circulating endothelial precursors: mystery, reality, and promise | Q40741679 | ||
| Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow | Q40923233 | ||
| Specificity of hematopoietic stem cell homing | Q40977261 | ||
| Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants | Q41140250 | ||
| BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics | Q41153338 | ||
| Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells | Q41217559 | ||
| Homing and trafficking of hemopoietic progenitor cells | Q41289025 | ||
| Stem cell proliferation: ex vivo and in vivo observations | Q41642132 | ||
| Effects of angiogenesis inhibitors on multistage carcinogenesis in mice | Q41648802 | ||
| Regulation of hematopoiesis by microvascular endothelium | Q41708973 | ||
| Purification and characterization of mouse hematopoietic stem cells | Q42065991 | ||
| Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells | Q42446075 | ||
| Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells | Q42498432 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain | Q43784472 | ||
| Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells | Q45147173 | ||
| Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. | Q45880303 | ||
| Immunologic barriers to hepatic adenoviral gene therapy for transplantation | Q45880538 | ||
| Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. | Q48073084 | ||
| Developmental potential and dynamic behavior of hematopoietic stem cells. | Q52261166 | ||
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
| The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities | Q59261168 | ||
| Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth | Q61942746 | ||
| Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo | Q68037453 | ||
| Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices | Q71487331 | ||
| In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells | Q73098003 | ||
| VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix | Q73119438 | ||
| Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1 | Q73229612 | ||
| The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood | Q73263841 | ||
| Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines | Q74167839 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| P433 | issue | 10 | |
| P921 | main subject | endothelium | Q111140 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 631-641 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors | |
| P478 | volume | 9 |
| Q33963837 | A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors |
| Q45879506 | A realistic chance for gene therapy in the near future |
| Q45010379 | Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds |
| Q36232794 | An overview of myoblast transplantation for myocardial regeneration |
| Q41529629 | Bone marrow-derived cells and their conditioned medium induce microvascular repair in uremic rats by stimulation of endogenous repair mechanisms |
| Q34768337 | Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma |
| Q36064553 | CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. |
| Q26795443 | Cell Therapy in Patients with Critical Limb Ischemia |
| Q35095397 | Cell physiology as a variable in gene transfer to endothelium |
| Q37338896 | Cell therapy of peripheral arterial disease: from experimental findings to clinical trials |
| Q36613812 | Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer |
| Q36447619 | Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer |
| Q43622985 | Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab |
| Q53262764 | Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. |
| Q28751438 | Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine |
| Q51867950 | Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. |
| Q79117080 | Divergent effects of GM‐CSF and TGFβ1on bone marrow‐ derived macrophage arginase‐1 activity, MCP‐1 expression, and matrix‐metalloproteinase‐12: a potential role during arteriogenesis |
| Q36367251 | Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease |
| Q33572686 | Endothelial progenitor cells in peripheral blood may serve as a biological marker to predict severe acute pancreatitis |
| Q36772905 | Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease |
| Q35218710 | Endothelial progenitor cells: precursors for angiogenesis |
| Q36305347 | Endurance Exercise Mobilizes Developmentally Early Stem Cells into Peripheral Blood and Increases Their Number in Bone Marrow: Implications for Tissue Regeneration. |
| Q41483706 | Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes |
| Q36819627 | Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect? |
| Q64946827 | Growth Factors and Cell Homing in Dental Tissue Regeneration. |
| Q37996791 | Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation |
| Q48138180 | Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas |
| Q61806121 | Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma |
| Q89558892 | Mobilized peripheral blood: an updated perspective |
| Q34402223 | Myocardial regeneration with bone-marrow-derived stem cells |
| Q41825489 | Nanoglycan complex formulation extends VEGF retention time in the lung |
| Q36749464 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. |
| Q33649852 | Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. |
| Q37122081 | Rho GTPases and regulation of hematopoietic stem cell localization |
| Q40743408 | SDF-1 is both necessary and sufficient to promote proliferative retinopathy. |
| Q33396460 | SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study |
| Q48146328 | Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling |
| Q79152271 | Significance of circulating endothelial progenitor cells in hepatocellular carcinoma |
| Q34361212 | Stem cells and cell therapies for cystic fibrosis and other lung diseases |
| Q36188910 | Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion |
| Q52050425 | Targeting gene expression in the mouse somite: adenovirus-mediated gene delivery and whole embryo culture. |
| Q48561768 | Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke |
| Q34327636 | Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse |
| Q42926963 | The Role of Stem Cells in Wound Angiogenesis |
| Q37858940 | The brain tumor microenvironment. |
| Q37989468 | The brain tumor microenvironment. |
| Q34404695 | Therapeutic angiogenesis and vasculogenesis for tissue regeneration |
| Q36976439 | Therapeutic myocardial angiogenesis |
| Q28207902 | Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration |
| Q35847986 | Tie2 activation contributes to hemangiogenic regeneration after myelosuppression |
| Q34694874 | Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model |
| Q33624863 | Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy |
| Q29619849 | Tumorigenesis and the angiogenic switch |
| Q43267629 | Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway |
| Q43496042 | Vascular endothelial growth factor stimulates endothelial colony forming cells proliferation and tubulogenesis by inducing oscillations in intracellular Ca2+ concentration. |
Search more.